Works matching IS 10837159 AND DT 2020 AND VI 25 AND IP 5

Results: 33
    1
    2
    3
    4
    5

    In Reply.

    Published in:
    Oncologist, 2020, v. 25, n. 5, p. e876, doi. 10.1634/theoncologist.2020-0059
    By:
    • Bilen, Mehmet Asim;
    • Master, Viraj A.;
    • Harvey, R. Donald
    Publication type:
    Article
    6

    Impact on Health‐Related Quality of Life of Parenteral Nutrition for Patients with Advanced Cancer Cachexia: Results from a Randomized Controlled Trial.

    Published in:
    Oncologist, 2020, v. 25, n. 5, p. e843, doi. 10.1634/theoncologist.2019-0856
    By:
    • Bouleuc, Carole;
    • Anota, Amélie;
    • Cornet, Cécile;
    • Grodard, Ghislain;
    • Thiery‐Vuillemin, Antoine;
    • Dubroeucq, Olivier;
    • Crétineau, Nathalie;
    • Frasie, Véronique;
    • Gamblin, Vincent;
    • Chvetzoff, Gisèle;
    • Favier, Laure;
    • Tournigand, Christophe;
    • Grach, Marie‐Christine;
    • Raynard, Bruno;
    • Salas, Sébastien;
    • Capodano, Géraldine;
    • Pazart, Lionel;
    • Aubry, Régis
    Publication type:
    Article
    7
    8
    9

    Renaissance of Radiotherapy in Intestinal Lymphoma? 10‐Year Efficacy and Tolerance in Multimodal Treatment of 134 Patients: Follow‐up of Two German Multicenter Consecutive Prospective Phase II Trials.

    Published in:
    Oncologist, 2020, v. 25, n. 5, p. e816, doi. 10.1634/theoncologist.2019-0783
    By:
    • Reinartz, Gabriele;
    • Molavi Tabrizi, Caroline;
    • Liersch, Ruediger;
    • Ullerich, Hansjoerg;
    • Hering, Dominik;
    • Willborn, Kay;
    • Schultze, Juergen;
    • Micke, Oliver;
    • Ruebe, Christian;
    • Fischbach, Wolfgang;
    • Bentz, Martin;
    • Daum, Severin;
    • Pott, Christiane;
    • Tiemann, Markus;
    • Moeller, Peter;
    • Neubauer, Andreas;
    • Wilhelm, Martin;
    • Lenz, Georg;
    • Berdel, Wolfgang E.;
    • Willich, Normann
    Publication type:
    Article
    10
    11
    12
    13

    Etiology and Prognosis of Pneumonia in Patients with Solid Tumors: A Prospective Cohort of Hospitalized Cases.

    Published in:
    Oncologist, 2020, v. 25, n. 5, p. e861, doi. 10.1634/theoncologist.2019-0031
    By:
    • Fernández‐Cruz, Ana;
    • Ortega, Laura;
    • García, Gonzalo;
    • Gallego, Iria;
    • Álvarez‐Uría, Ana;
    • Chamorro‐de‐Vega, Esther;
    • García‐López, José Javier;
    • González‐del‐Val, Ricardo;
    • Martín‐Rabadán, Pablo;
    • Rodríguez, Carmen;
    • Pedro‐Botet, María Luisa;
    • Martín, Miguel;
    • Bouza, Emilio
    Publication type:
    Article
    14
    15
    16
    17
    18

    Real‐World Assessment of Clinical Outcomes Among First‐Line Sunitinib Patients with Clear Cell Metastatic Renal Cell Carcinoma (mRCC) by the International mRCC Database Consortium Risk Group.

    Published in:
    Oncologist, 2020, v. 25, n. 5, p. 422, doi. 10.1634/theoncologist.2019-0605
    By:
    • Savard, Marie‐France;
    • Wells, J. Connor;
    • Graham, Jeffrey;
    • Dudani, Shaan;
    • Steinharter, John A.;
    • McGregor, Bradley A.;
    • Donskov, Frede;
    • Bjarnason, Georg A.;
    • Vaishampayan, Ulka N.;
    • Hansen, Aaron R.;
    • Iafolla, Marco A.J.;
    • Zanotti, Giovanni;
    • Huynh, Lynn;
    • Chang, Rose;
    • Duh, Mei S.;
    • Heng, Daniel Y.C.
    Publication type:
    Article
    19
    20

    A Pilot Feasibility Study of Yttrium‐90 Liver Radioembolization Followed by Durvalumab and Tremelimumab in Patients with Microsatellite Stable Colorectal Cancer Liver Metastases.

    Published in:
    Oncologist, 2020, v. 25, n. 5, p. 382, doi. 10.1634/theoncologist.2019-0924
    By:
    • Wang, Chongkai;
    • Park, John;
    • Ouyang, Ching;
    • Longmate, Jeff A.;
    • Tajon, Michael;
    • Chao, Joseph;
    • Lim, Dean;
    • Sandhu, Jaideep;
    • Yin, Hongwei Holly;
    • Pillai, Raju;
    • Gozo, Maricel C.;
    • Avalos, Christian;
    • Egelston, Colt A.;
    • Lee, Peter P.;
    • Fakih, Marwan
    Publication type:
    Article
    21
    22

    Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5‐Fluorouracil, and Leucovorin Versus Oxaliplatin, 5‐Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG‐ACRIN Research Group (E5204)

    Published in:
    Oncologist, 2020, v. 25, n. 5, p. e798, doi. 10.1634/theoncologist.2019-0437
    By:
    • Chakravarthy, A. Bapsi;
    • Zhao, Fengmin;
    • Meropol, Neal J.;
    • Flynn, Patrick J.;
    • Wagner, Lynne I.;
    • Sloan, Jeffrey;
    • Diasio, Robert B.;
    • Mitchell, Edith P.;
    • Catalano, Paul;
    • Giantonio, Bruce J.;
    • Catalano, Robert B.;
    • Haller, Daniel G.;
    • Awan, Rashid A.;
    • Mulcahy, Mary F.;
    • O'Brien, Timothy E.;
    • Santala, Roger;
    • Cripps, Christine;
    • Weis, John R.;
    • Atkins, James N.;
    • Leichman, Cynthia G.
    Publication type:
    Article
    23

    An Open‐Label, Single‐Arm, Two‐Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas.

    Published in:
    Oncologist, 2020, v. 25, n. 5, p. e782, doi. 10.1634/theoncologist.2019-0490
    By:
    • Chen, Ming‐Huang;
    • Chou, Wen‐Chi;
    • Hsiao, Chin‐Fu;
    • Jiang, Shih Sheng;
    • Tsai, Hui‐Jen;
    • Liu, Yi‐Chang;
    • Hsu, Chiun;
    • Shan, Yan‐Shen;
    • Hung, Yi‐Ping;
    • Hsich, Chia‐Hsun;
    • Chiu, Chao‐Hua;
    • Liu, Ta‐Chih;
    • Cho, Shih‐Feng;
    • Liu, Tsang‐Wu;
    • Chao, Yee
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33